Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today reported results for...
Source: prnewswire.com